Wedbush Bullish On Sarepta's Eteplirsen Data By: Benzinga via Benzinga July 20, 2016 at 08:42 AM EDT Wedbush’s Heather Behanna believes there is a “good chance” that eteplirsen would receive approval in 3Q16, if ... Read More >> Related Stocks: Sarepta Therapeutics